Adam Richard, Duong Tim, Hodges Laura, Staeger-Hirsch Christine, Maldjian Takouhie
Stony Brook University, 100 Nicolls Road, Stony Brook, NY, 11794, USA.
Department of Radiology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY, USA.
Radiol Case Rep. 2022 Jun 10;17(8):2841-2849. doi: 10.1016/j.radcr.2022.04.028. eCollection 2022 Aug.
Axillary lymphadenopathy has been reported after ipsilateral COVID-19 vaccination and can cause confusion for possible malignancy [1]. Intrinsic findings isolated to the breast has not been previously reported. This is the first case series of ipsilateral reversible changes of diffuse axillary tail trabecular thickening on screening mammography in totally asymptomatic patients in connection with COVID vaccination, 3 of which were isolated findings, confirmed by complete resolution of all imaging findings on follow up. In all instances, imaging was performed within 1 week of the first or third dose of an mRNA COVID-19 vaccine. These findings can be confused with breast cancer. Spontaneous resolution distinguishes vaccine-related findings from breast cancer.
已有报道称,同侧接种新冠疫苗后会出现腋窝淋巴结病,这可能会让人将其与可能的恶性肿瘤相混淆[1]。此前尚未有仅局限于乳房的内在表现的报道。这是首例关于在完全无症状的患者中,与新冠疫苗接种相关的筛查乳腺钼靶上出现同侧弥漫性腋窝尾部小梁增厚的可逆性改变的病例系列,其中3例为孤立性表现,通过随访时所有影像学表现完全消退得以证实。在所有病例中,影像学检查均在接种第一剂或第三剂mRNA新冠疫苗后的1周内进行。这些表现可能会与乳腺癌相混淆。自发消退可将与疫苗相关的表现与乳腺癌区分开来。